CELU Celularity Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CELU

Price (delayed)

$0.9862

Market cap

$28.55M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.59

Enterprise value

$53.08M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 4
Highlights
CELU's debt is down by 41% year-on-year but it is up by 32% since the previous quarter
CELU's equity has dropped by 89% since the previous quarter
The gross profit has dropped by 83% year-on-year and by 68% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of CELU

CELU stock price

How has the Celularity stock price performed over time
Intraday
-3.31%
1 week
-0.48%
1 month
0.21%
1 year
-52.13%
YTD
-11.15%
QTD
-25.85%

Financial performance

How have Celularity's revenue and profit performed over time
Revenue
$26.55M
Gross profit
$6.48M
Operating income
-$61.31M
Net income
-$91.72M
Gross margin
24.4%
Net margin
-345.4%
Celularity's operating margin has shrunk by 92% QoQ
The gross profit has dropped by 83% year-on-year and by 68% since the previous quarter
CELU's net margin has dropped by 74% since the previous quarter
The gross margin has dropped by 66% year-on-year and by 52% since the previous quarter

Price vs fundamentals

How does CELU's price correlate with its fundamentals

Growth

What is Celularity's growth rate over time

Valuation

What is Celularity stock price valuation
P/E
N/A
P/B
N/A
P/S
0.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2
Celularity's EPS has decreased by 36% YoY and by 8% QoQ
CELU's equity has dropped by 89% since the previous quarter
CELU's P/S is 90% below its 5-year quarterly average of 10.3 and 11% below its last 4 quarters average of 1.1
CELU's revenue has dropped by 51% year-on-year and by 35% since the previous quarter

Efficiency

How efficient is Celularity business performance
CELU's return on invested capital has dropped by 141% year-on-year and by 49% since the previous quarter
CELU's ROA has dropped by 82% year-on-year and by 20% since the previous quarter
Celularity's return on sales has shrunk by 78% QoQ

Dividends

What is CELU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CELU.

Financial health

How did Celularity financials performed over time
CELU's total assets is 26% smaller than its total liabilities
Celularity's current ratio has shrunk by 61% YoY and by 6% QoQ
The quick ratio has declined by 43% year-on-year
The debt to equity has plunged by 114% YoY but it has grown by 31% from the previous quarter
CELU's equity has dropped by 89% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.